Skip to main content

Medical Image Analysis Software Market to Witness 7.8% CAGR by 2031 | SkyQuest Technology

Written by Customer Service on . Posted in Mergers And Acquisitions.

Westford,USA, Nov. 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Medical Image Analysis Software Market will attain the value of USD 5.93 billion by 2031, with a CAGR of 7.8% during the forecast period (2024-2031). The increasing prevalence of the chronic diseases, coupled with increased demand for diagnostic imaging solutions has seen a significant expansion in the market, requiring medical imaging solutions. Healthcare professionals imaging organs at their views, evaluate surgical results closely, and assess tumor size preoperatively magnetic resonance imaging (MRI) & computed Treatment with tomography (CT) imaging is heavily dependent on imaging technology.
The increasing prevalence of the chronic diseases, coupled with increased demand for diagnostic imaging solutions has seen a significant expansion in the market, requiring medical imaging solutions. The main objective of the medical image analysis software market is to provide advanced tools and algorithms that aid in quantitative and qualitative analysis of medical images. These software solutions help detect abnormalities, measure body structure, monitor disease progression, and plan surgery.

Download a detailed overview:
https://www.skyquestt.com/sample-request/medical-image-analysis-software-market

Browse in-depth TOC on “Medical Image Analysis Software Market” 

  • Pages – 197
  • Tables – 63
  • Figures – 75

Medical Image Analysis Software Market Overview:

Report CoverageDetails
Market Revenue in 2023USD 3.25 Billion
Estimated Value by 2031USD 5.93 Billion
Growth RatePoised to grow at a CAGR of 7.8%
Forecast Period2024–2031
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredType, Image Type, Modality, Application, End User
Geographies CoveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report HighlightsUpdated financial information / product portfolio of players
Key Market OpportunitiesGrowing Emphasis on Cloud-Based Solutions
Key Market DriversGrowing Demand for Accurate and Timely Diagnosis

Integrated Software Segment to Dominate Due to Increasing Adoption of Integrated Systems
The global medical image analysis software market dominated with the aid of the integrated software segment. The large market share of the integrated solutions can be attributed to the benefits associated with its use. The integrated equipment is designed specifically for radiology applications, with the aim of improving efficiency. An example of such software is Philip’s Xcelera Cardiology Information Management, which provides the integrated image management capabilities and facilitates advanced medical services, thereby improving clinical efficiency.

Ultrasound Image Analysis Software Segment to Drive Market Due to Increased Accuracy
The ultrasound image analysis software segment is expected to witness the fastest CAGR in the coming years. This can be attributed to several advantages such as faster analysis and increased accuracy. Furthermore, ultrasound imaging is non-invasive and does no longer contain exposure to ionizing radiation, making it ideal in lots of healthcare programs. These elements have played an important role inside the development of this segment.

North America is Dominating Due to Rising Adoption of Healthcare IT
North America dominated the marketplace with 36.7% sales share in 2023. The growth on this region may be attributed to well-established healthcare centers equipped with advanced diagnostic equipment in offering desirable government guidelines selling adoption of healthcare IT. For example, in January 2022, MIM Software Inc. have announced a partnership with GenesisCare, a global integrated cancer care provider, with the goal of expanding patient access worldwide.

The Asia-Pacific region in the market is expected to grow at a substantial CAGR during the forecast period, owing to the high adoption of medical image analysis software by the healthcare professionals in the region. Increasing awareness of the advantages associated with those systems is a key component predicted to market growth. Furthermore, rising healthcare costs and excessive income levels in countries which include China and India contribute to the growth of the regional market.

Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/medical-image-analysis-software-market

Drivers

  • Growing Demand for Accurate and Timely Diagnosis
  • Advancements in Imaging Technologies

Restraints

  • High Cost of Implementation and Maintenance
  • Data Privacy and Security Concerns

Prominent Players in Medical Image Analysis Software Market
The following are the Top Medical Image Analysis Software Market Companies

  • IBM Corporation (US)
  • General Electric Company (US)
  • Philips Healthcare (Netherlands)
  • Siemens Healthineers (Germany)
  • Agfa-Gevaert Group (Belgium)
  • Merge Healthcare (IBM Watson Health) (US)
  • MIM Software Inc. (US)
  • Canon Medical Systems Corporation (Japan)
  • Carestream Health (US)
  • McKesson Corporation (US)
  • Fujifilm Holdings Corporation (Japan)
  • Sectra AB (Sweden)
  • Mirada Medical Limited (UK)
  • Ziosoft Inc. (Japan)
  • Aidence (Netherlands)
  • MeVis Medical Solutions AG (Germany)

View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/medical-image-analysis-software-market

Key Questions Answered in Medical Image Analysis Software Market Report

  • How big is the Global Medical Image Analysis Software Market?
  • What are the key drivers of Global Medical Image Analysis Software Market size?
  • Who are the key players in the Medical Imaging Analysis Software Market?
  • Which is the fastest growing region in the Medical Imaging Analysis Software Market?

This report provides the following insights:

  • Analysis of key drivers (growing demand for accurate and timely diagnosis, advancements in imaging technologies), restraints (high cost of implementation and maintenance, data privacy and security concerns), opportunities (Growing emphasis on cloud-based solutions), influencing the growth of medical image analysis software market.
  • Market Dynamics: Comprehensive information about the various products offered by the dominant players in the medical image analysis software market.
  • Product Development/Innovation: An overview of emerging trends, R&D activities and product launches in the medical image analysis software market. 
  • Market Growth: Detailed information on profitable growing industries. 
  • Market Trends: Complete information about new products, emerging geographical areas and recent developments in the market.
  • Competitive Analysis: An in-depth analysis of the market segments, growth strategies, revenue analysis, and products of the key market players.

Related Reports:
Supply Chain Management Market
Voice Assistant Application Market
eDiscovery Software Market
ESG Software Market
Unified Communications Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.